MOORE ALISON
SEC CIK 1754937 · EDGAR
BoughtSold
Most active insiders at CDXS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Opaleye Management Inc. | 10% | — | $2.59M |
| 2 | MOORE ALISON | Pres, CEO, Dir | — | $20.7K |
| 3 | Erbez Georgia | See Remarks | — | $20.7K |
| 4 | Lutz Stefan | CSO | — | $17.9K |
| 5 | WOLF DENNIS P | Dir | — | $14.0K |
| 6 | De Vre Raymond | Dir | — | $8,632 |
| 7 | DILLY STEPHEN GEORGE | Dir | — | — |
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-09 | 2026-02-06 | CDXS | CODEXIS, INC. | MOORE ALISON | Pres, CEO, Dir | S - Sale | $1.31 | -3,826 | 250.5K | -2% | -$5,012 | |
| D | 2025-11-17 | 2025-11-13 | CDXS | CODEXIS, INC. | MOORE ALISON | Pres, CEO | A - Grant | $0.00 | +85.0K | 254.3K | +50% | $0 |
| 2025-10-15 | 2025-10-13 | CDXS | CODEXIS, INC. | MOORE ALISON | Chief Technical Off | S - Sale | $2.51 | -6,239 | 169.3K | -4% | -$15.7K | |
| D | 2025-02-07 | 2025-02-05 | CDXS | CODEXIS, INC. | MOORE ALISON | Chief Technical Off | A - Grant | $0.00 | +26.9K | 175.6K | +18% | $0 |
| D | 2024-10-10 | 2024-10-10 | CDXS | CODEXIS, INC. | MOORE ALISON | Chief Technical Off | A - Grant | $0.00 | +50.0K | 148.7K | +51% | $0 |
| 2024-06-13 | 2024-06-11 | CDXS | CODEXIS, INC. | MOORE ALISON | Dir | A - Grant | $0.00 | +30.1K | 98.7K | +44% | $0 | |
| 2023-06-15 | 2023-06-13 | CDXS | CODEXIS, INC. | MOORE ALISON | Dir | A - Grant | $0.00 | +34.6K | 68.6K | +102% | $0 | |
| D | 2023-03-24 | 2023-03-22 | ALLO | Allogene Therapeutics, Inc. | MOORE ALISON | Chief Technical Off | A - Grant | $0.00 | +558.1K | 672.7K | +487% | $0 |
| 2023-03-16 | 2023-03-14 | ALLO | Allogene Therapeutics, Inc. | MOORE ALISON | Chief Technical Off | F - Tax | $5.51 | -8,351 | 114.6K | -7% | -$46.0K | |
| 2022-06-16 | 2022-06-14 | CDXS | CODEXIS, INC. | MOORE ALISON | Dir | A - Grant | $0.00 | +11.3K | 34.0K | +50% | $0 | |
| 2022-03-17 | 2022-03-15 | ALLO | Allogene Therapeutics, Inc. | MOORE ALISON | Chief Technical Off | S - Sale | $7.63 | -8,698 | 120.4K | -7% | -$66.4K |
Purchase Sale Sale after option exercise All abbreviations